Company / Capital Expenditures
Equillium, Inc. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$85.0K
FY2025
5-year range
$50.0K / $279.0K
FY2022-FY2025
Trend
+70.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $279,000 to $85,000 over the past 2 years.
Based on SEC 10-K filings.
$85,000 in FY2025 with a 3-year CAGR of +14.2%.
Declined from $279,000 to $85,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +14.2%, indicating consistent growth.
- In FY2025, capital expenditures increased 70.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $85.0K | +70.0% |
| FY2024 | $50.0K | -82.1% |
| FY2023 | $279.0K | +389.5% |
| FY2022 | $57.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026